Burning mouth syndrome
From IDWiki
Revision as of 18:25, 26 September 2022 by Aidan (talk | contribs) (Created page with "* Syndrome of chronic oral pain * Mostly affects perimenopausal or postmenopaulsa women * Pathophysiology thought to be neuropathic * Pain is characterized as burning of oral mucosa, and may have associated dysgeusia, paresthesia, dysesthesia, and xerostomia * Treatments include alpha-lipoic acid (ALA) supplementation, topical clonazepam, gabapentin, combination ALA and gabapentin, Catauma, or bupivacaine")
- Syndrome of chronic oral pain
- Mostly affects perimenopausal or postmenopaulsa women
- Pathophysiology thought to be neuropathic
- Pain is characterized as burning of oral mucosa, and may have associated dysgeusia, paresthesia, dysesthesia, and xerostomia
- Treatments include alpha-lipoic acid (ALA) supplementation, topical clonazepam, gabapentin, combination ALA and gabapentin, Catauma, or bupivacaine
References
- ^ YF Liu, Y Kim, T Yoo, P Han, JC Inman. Burning mouth syndrome: a systematic review of treatments. Oral Diseases. 2017;24(3):325-334. doi:10.1111/odi.12660.
